Abortinduktion bei fortgeschrittenen Schwangerschaften

  • W. Rath
  • T. Krauss
  • W. Kuhn
Conference paper

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Andersen LF, Poulsen HK, Sorensen SS, Christensen BM, Sponland G, Skjeldestad FE (1989) Termination of second trimester pregnancy with gemeprost vaginal pessaries and intraamniotic PGF2α. Europ J Obstet Gynecol Reprod Biol 31: 1–7CrossRefGoogle Scholar
  2. Baulieu EE (1985) RU 486: An antiprogestin steroid with contragestive activity in women. In: Baulieu EE, Segal SJ (Hrsg) The antiprosterone steroid RU 486 and human fertility control. Plenum, New York S 1–12Google Scholar
  3. Bygdeman M (1990) Non-invasive methods for termination of second trimester pregnancy. Baillieres Clin Obstet Gynaecol 4: 351–359PubMedCrossRefGoogle Scholar
  4. Cameron IT, Michie AF, Baird DT (1987) Prostaglandin-induced pregnancy termination: further studies using gemeprost vaginal pessaries in the early second trimester. Prostaglandins 34: 111–117PubMedCrossRefGoogle Scholar
  5. Di Lieto A, Catalano D, Albano G, Ucello N, Civetta A et al. (1991) Uterine motility and cervical ripening in second trimester elective abortion by two different PGE analogues. Clin Exp Obstet Gynecol 18: 251–259PubMedGoogle Scholar
  6. Dimov V, Green K, Bygdeman M, Konishi Y, Imaki K, Hayashi M (1983) Gas chromotographicmass spectrometric quantitation of 16,16-dimethyl trans-delta 2-PGE1. Prostaglandins 25: 225–235PubMedCrossRefGoogle Scholar
  7. Goeschen K (1989) Behandlung mit Prostaglandinen in Geburtshilfe und Gynäkologie. Enke, StuttgartGoogle Scholar
  8. Gottlieb C, Bygdeman M (1991) The use of anti-progestin (RU 486) for termination of second trimester pregnancy. Acta Obstet Gynecol Scand 70: 199–203PubMedCrossRefGoogle Scholar
  9. Hill NCW, Seiinger M, Ferguson J, Lopez Bernal A, Mackenzie JZ (1990) The physiological and clinical effects on progesterone inhibition with mifepristone (RU 486) in the second trimester. Br J Obstet Gynaec 97: 487–492CrossRefGoogle Scholar
  10. Kajanoja P (1990) Is preoperative cervical softening necessary in termination of pregnancy in nulliparous women? Zent B1 Gynäkol 112: 589–591Google Scholar
  11. Karim SMM (1982) Clinical applications of prostaglandins in obstetrics and gynaecology. An Acad Med (Singapore) 11: 491–502Google Scholar
  12. Lehfeldt H (1977) Komplikationsraten und Organisation nach Legalisierung der Schwangerschaftsunterbrechung im Staate New York. In: Beller FK, Böttcher HD (Hrsg) Moderne Kontrazeption, Thieme, Stuttgart S 97–103Google Scholar
  13. Querido L, Haspels AA (1990) Late second trimester abortion with 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (Gemeprost). Contraception 42: 43–49PubMedCrossRefGoogle Scholar
  14. Rath W, Kuhn W (1985) Cervical ripening and induction of labour in cases of intrauterine fetal death. Int J Gynaecol Obstet 23: 387–394PubMedCrossRefGoogle Scholar
  15. Rath W, Kuhn W (1987) Die Anwendung von Prostaglandinen zur Schwangerschaftsbeendigung im I. Trimenon. Gynäkol prax 11: 113–126Google Scholar
  16. Rath W, Kuhn W (1987) Die Anwendung von Prostaglandinen zur Schwangerschaftsbeendigung im I. und II. Trimenon. Wien Klin Wschr 99: 741–751Google Scholar
  17. Rath W, Kuhn W (1988) Prostaglandine in Gynäkologie und Geburtshilfe, Indikationsspektrum und Anwendungsmöglichkeiten. Arzneimitteltherapie 6: 111–121Google Scholar
  18. Rath W, Gerland W, Osmers R (1991) Schwangerschaftsbeendigung im II. und III. Trimenon mit Prostaglandinen in Abhängigkeit vom Zervixstatus. Zent B1 Gynäkol 113: 519–526Google Scholar
  19. Rodger MW, Baird DT (1990) Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaec 97: 41–4CrossRefGoogle Scholar
  20. Rosenblatt WH, Cioffi AM, Sinatra R, Saberski LR, Silverman DG (1991) Metoclopramide: an analgesic adjuvant to patient - controlled analgesia. Anesth Analg 73: 553–555PubMedGoogle Scholar
  21. Sakamoto S, Satoh K, Nishiya I, Kunimoto L, Chimura T et al. (1982) Abortifacient effect and uterine cervix-dilating action of 16,16-dimethyl-trans-delta 2 PGE1-metyl ester (ONO 802) in the form of a vaginal suppository (a randomized, double-blind controlled study in the second trimester of pregnancy). Prostaglandins Leukotrienes Med 9: 349–359CrossRefGoogle Scholar
  22. Schmidt W, Ditz S (1988) Abortinduktion im 2. und 3. Schwangerschaftstrimenon In: Haller U, Kubli F, Husslein P (Hrsg) Prostaglandine in Geburtshilfe und Gynäkologie. Springer, Berlin, Heidelberg, New York, S 114–122CrossRefGoogle Scholar
  23. Steward GK, Goldstein P (1972) Medical and surgical complications of therapeutic abortions. Obstet Gynecol 4: 539–545Google Scholar
  24. Thong KJ, Baird DT (1992) An open study com-paring two regimens of gemeprost for the termination of pregnancy in the second trimester. Acta Obstet Gynecol Scand 71: 191–196PubMedCrossRefGoogle Scholar
  25. Tietze C, Lewit S (1977) Legal abortion. Sci Amer 236: 21–28Google Scholar
  26. Toppozada M, Ismail A A (1990) Intrauterine administration of drugs for termination of pregnancy in the second trimester. Baillieres Clin Obstet Gynaecol 4: 327–349PubMedCrossRefGoogle Scholar
  27. Urquhart DR, Templeton AA (1987) Mifepristone (RU 586) and second trimester termination. Lancet 11: 1405CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • W. Rath
  • T. Krauss
  • W. Kuhn

There are no affiliations available

Personalised recommendations